Millipore Corporation which acquired Novaseptic a couple of years ago, has recently introduced the new NovaSeptum AV (Accurate Volume) system designed to meet the challenges faced in the aseptic and sterile sampling during the production of today’s high-value biotherapeutic products. Taking accurate small volume samples with minimal waste of the valuable drug product improves product yield.
The NovaSeptum AV system is a closed (similar to Novaseptic's other sampling systems which avoid cross contamination), accurate sampling system that enables the production personnel to obtain a small-volume product intermediate samples easily and efficiently avoiding the risk of cross contamination. This device measures to milliliter accuracy and thereby improves the sampling efficiency while reducing potential product waste. This syringe systems allows storing the sample for testing at later stages also.
The closed design of the NovaSeptum AV system ensures that the drug product and sample are always enclosed in a sterile, closed environment. Being a sterile, disposable and closed sampling system, the NovaSeptum AV system eliminates the need to clean and sterilize traditional sample containers and thereby ensures that the product is secure from point of sampling to testing, by avoiding any cross contamination.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment